Skip to main content

Table 3 Synovial fluid analysis

From: Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis – a prospective cohort study

Analysis All (n = 105) Responders (n = 61) Non-responders (n = 44) P-value
sf-TNF (pg/mL) 42 (0 to 1,128) 51 (0 to 1,128) 36 (0 to 182) 0.706
sf-IL6 (pg/mL) 734 (0 to 10,000) 636 (0 to 10,000) 1,062 (0 to 10,000) 0.625
sf-VEGF (pg/mL) 778 (128 to 2,518) 622 (128 to 2.518) 998 (282 to 1,926) 0.002
sf-MMP3 (pg/mL) 5,367 (64 to 143,896) 6,696 (64 to 143,896) 5189 (524 to 72,922) 0.686
sf-COMP (U/L) 58.5 ± 36.0 54.4 ± 27.1 63.6 ± 44.6 0.220
sf-Mono (x109/L) 1.7 (0 to 132.6) 1.9 (0 to 132.6) 1.5 (0 to 7.1) 0.208
sf-Poly (x109/L) 1.65 (0 to 32.1) 1.6 (0 to 19.5) 1.7 (0 to 32.1) 0.801
  1. Median (range), mean ± SD, Bold figures: P <0.003. COMP, cartilage oligomeric matrix protein; MMP3, matrix metalloproteinase 3; SD, standard deviation; sf, synovial fluid; VEGF, vascular endothelial growth factor.